Adrenaline (epinephrine) is a catecholamine hormone and neurotransmitter released from chromaffin cells in the adrenal Medulla and from sympathetic nervous system terminals in response to acute stress, threat, or metabolic challenge. It orchestrates the rapid fight-or-flight response through coordinated cardiovascular, metabolic, immune, and neural effects, preparing the organism for immediate physical action by redistributing energy and resources to survival-critical systems.
Think of adrenaline as the fire alarm and sprinkler system for your body's entire building. When threat is detected, it doesn't just ring a bell—it instantly redirects water pressure (blood flow) away from the cafeteria and bathrooms (digestion, reproduction) and floods the stairwells and exits (muscles, heart, lungs). It also unlocks the emergency generator room (liver glycogen stores) to dump extra fuel into the system, opens all the windows for ventilation (bronchodilation), and sends security guards from their break room into active patrol (immune cell mobilization). The whole building shifts from "business as usual" to "survival mode" in seconds. The fire alarm can't stay on forever—if it does, the building falls apart from constant emergency operations. Chronic adrenaline is like a fire alarm that never turns off: the sprinklers flood the wrong rooms, the generator runs dry, and the security guards collapse from exhaustion.
Adrenaline synthesis follows the catecholamine pathway in chromaffin cells of the adrenal medulla and sympathetic postganglionic neurons:
Synthesis cascade:
Tyrosine → (tyrosine hydroxylase) → L-DOPA → (DOPA decarboxylase) → Dopamine → (dopamine β-hydroxylase) → Noradrenaline → (phenylethanolamine N-methyltransferase, PNMT) → Adrenaline
PNMT is only expressed in adrenal chromaffin cells (requires high local Cortisol from adrenal cortex for induction), which is why adrenal medulla produces adrenaline while sympathetic nerve terminals produce primarily noradrenaline.
Release mechanism:
Sympathetic preganglionic neurons (acetylcholine) → nicotinic receptors on chromaffin cells → depolarization → Ca²⁺ influx → exocytosis of adrenaline-containing vesicles into bloodstream
Receptor signaling:
Adrenaline binds to Adrenoreceptors with differential affinity:
graph TD
A[Adrenaline] --> B["α1 receptors"]
A --> C["α2 receptors"]
A --> D["β1 receptors"]
A --> E["β2 receptors"]
A --> F["β3 receptors"]
B --> G["Gq → PLC → IP3/DAG → Ca²⁺ ↑"]
G --> H[Vasoconstriction in skin, gut, kidneys]
C --> I["Gi → cAMP ↓"]
I --> J[Negative feedback on NE/Epi release]
D --> K["Gs → cAMP ↑ → PKA activation"]
K --> L["↑ Heart rate SA node"]
K --> M["↑ Contractility ventricles"]
K --> N["↑ Lipolysis HSL activation"]
E --> O["Gs → cAMP ↑ → PKA"]
O --> P[Bronchodilation]
O --> Q[Vasodilation in muscle]
O --> R[Glycogenolysis in muscle]
O --> S[Tremor via muscle activation]
F --> T["Gs → cAMP ↑"]
T --> U[Lipolysis in adipocytes]
T --> V[Thermogenesis in brown fat]
Metabolic effects:
- Liver: β2 receptors → cAMP → PKA → phosphorylase kinase → Glycogenolysis + Gluconeogenesis (PEPCK, G6Pase upregulation)
- Muscle: β2 receptors → glycogenolysis (local glucose for contraction; muscle lacks G6Pase so no systemic release)
- Adipose: β3 (primary) and β1 receptors → PKA → Hormone-sensitive lipase (HSL) phosphorylation → Lipolysis → Free fatty acids release
- Pancreas: α2 receptors → inhibits insulin secretion (permits hyperglycemia); β2 receptors → stimulates glucagon (amplifies hepatic glucose output)
Cardiovascular effects:
- β1 receptors in SA node → ↑ heart rate (positive chronotropy)
- β1 in ventricles → ↑ contractility (positive inotropy)
- α1 in arterioles → vasoconstriction (skin, splanchnic, renal beds)
- β2 in skeletal muscle arterioles → vasodilation (overrides α1 at high concentrations)
- Net effect: ↑ cardiac output (up to 5-fold), ↑ systolic BP, ↓ or ↔ diastolic BP (due to β2 vasodilation)
Immune effects:
- β2 receptors on leukocytes → demargination from spleen and bone marrow → Catecholamine-induced leukocytosis
- Redistribution: ↑ NK cells, neutrophils, monocytes in circulation
- Primes innate immunity for tissue damage (anticipatory stress response)
- Suppresses Th1/pro-inflammatory cytokines via β2-cAMP-PKA pathway
Metabolic inactivation:
- Plasma half-life: 2-3 minutes
- Enzymatic breakdown: COMT (catechol-O-methyltransferase) → metanephrine; monoamine oxidase (MAO) → 3,4-dihydroxymandelic acid
- Urinary metabolites: metanephrine, normetanephrine, vanillylmandelic acid (VMA)
Acute vs. Chronic Adrenaline Exposure:
The pathology in cPNI is not the acute spike (which is adaptive) but the failure to return to baseline. Chronic low-grade sympathetic activation creates a state of metabolic ambiguity—the body receives constant "emergency" signals but no resolution.
Clinical presentations of chronic adrenaline dysregulation:
Metamodel connections:
- Selfish systems: Adrenaline prioritizes immediate survival (brain, heart, muscle) at the expense of long-term health systems (gut, immune, reproduction). Chronic activation = selfish systems running unchecked.
- Evolutionary mismatch: Designed for acute physical threats (predator, fight); modern stressors (financial worry, social rejection) trigger same pathway but without physical discharge → no metabolic resolution.
Intervention implications:
- Vagal tone enhancement: Parasympathetic activation directly antagonizes sympathetic drive (see Vagus nerve, HRV)
- Breathwork: Slow, diaphragmatic breathing (4-6 breaths/min) shifts autonomic balance → ↓ sympathetic outflow from Rostral ventrolateral medulla (RVLM)
- Exercise: Provides metabolic "discharge" for adrenaline-mobilized substrates (glucose, FFAs); training increases β-receptor sensitivity at lower resting sympathetic tone
- Meditation: Reduces basal Noradrenaline and adrenaline via top-down cortical inhibition of Amygdala and Hypothalamus
- Avoid stimulants: Caffeine, nicotine → further β-receptor stimulation in already over-activated system
- Sleep optimization: Chronic sleep debt → ↑ baseline sympathetic tone and blunted HPA-sympathetic coordination
Biomarkers:
- Plasma adrenaline: Normal 10-50 pg/mL; acute stress can elevate 10-50 fold
- 24-hour urinary metanephrines: Screen for pheochromocytoma but also useful marker of chronic sympathetic activation
- Heart rate variability (HRV): Indirect measure of sympathovagal balance; low HRV = high sympathetic/low vagal
Key patient groups:
- PTSD, chronic anxiety: Hyperreactive adrenaline response to non-threatening stimuli
- Type 2 diabetes, metabolic syndrome: Chronic adrenaline contributes to insulin resistance
- Hypertension: Often driven by sympathetic overdrive before renin-angiotensin involvement
- Chronic fatigue syndrome: Paradoxical low adrenaline response to acute stress (exhausted system)
- Synthesized in adrenal medulla chromaffin cells and sympathetic nerve terminals
- Requires Cortisol to induce PNMT enzyme (converts noradrenaline → adrenaline)
- Plasma half-life: 2-3 minutes (very short-acting)
- Normal plasma concentration: 10-50 pg/mL at rest
- Acute stress increases levels 10-50 fold within seconds
- Binds all adrenergic receptors but highest affinity for β2 receptors
- Increases cardiac output up to 5-fold via β1 receptor stimulation
- Causes bronchodilation via β2 receptors (mechanism of epinephrine inhalers)
- Stimulates Lipolysis primarily via β3 receptors on adipocytes
- Inhibits insulin secretion (α2 pancreatic β-cells) and stimulates glucagon
- Mobilizes immune cells from spleen and bone marrow via β2 signaling
- Metabolized by COMT to metanephrine and MAO to VMA
- Peak adrenaline response occurs 2-5 minutes after stressor onset
- Chronic elevation seen in pheochromocytoma (tumor of chromaffin cells)
- β-blockers (e.g., propranolol) block adrenaline effects on heart and reduce anxiety symptoms
- Noradrenaline — immediate precursor to adrenaline; shares many receptor targets but different synthesis sites
- Cortisol — co-released during stress; cortisol induces PNMT enzyme and prolongs adrenaline effects by upregulating adrenoreceptors
- Adrenoreceptors — adrenaline exerts all effects through α1, α2, β1, β2, β3 receptor subtypes
- Tyrosine — amino acid starting point for entire catecholamine synthesis pathway
- COMT — primary metabolic enzyme; polymorphisms affect adrenaline clearance rate and stress resilience
- HPA axis — parallel neuroendocrine stress system; cortisol and adrenaline act synergistically
- Sympathetic nervous system — adrenaline is primary hormonal effector of sympathetic activation
- Insulin resistance — chronic adrenaline drives hepatic glucose production and impairs insulin signaling
- Lipolysis — adrenaline activates hormone-sensitive lipase via β-adrenergic-PKA pathway
- Glycogenolysis — adrenaline rapidly mobilizes liver and muscle glycogen to increase blood glucose
- Gluconeogenesis — β2 receptor activation upregulates PEPCK and G6Pase for glucose synthesis from amino acids
- Catecholamine-induced leukocytosis — adrenaline redistributes immune cells from marginated pools to circulation
- Leukocyte redistribution — prepares immune system for anticipated tissue damage during fight-or-flight
- Vagus nerve — parasympathetic counterbalance; vagal activation directly opposes adrenaline effects
- HRV — low heart rate variability reflects chronic sympathetic (adrenaline) dominance over vagal tone
- Chronic stress — sustained adrenaline elevation without recovery leads to metabolic and immune dysfunction
- Anxiety — central and peripheral catecholamine dysregulation share common neural substrates
- Exercise — acute adrenaline release during exercise improves receptor sensitivity; chronic exercise lowers resting sympathetic tone
- Breathwork — controlled breathing reduces sympathetic outflow and lowers circulating adrenaline
- Acute stress response — adrenaline is the rapid-onset component (seconds to minutes) of the integrated stress response
- Allostatic load — chronic adrenaline exposure is a major contributor to wear-and-tear on cardiovascular and metabolic systems
- Glucose — adrenaline acutely raises blood glucose through multiple pathways (glycogenolysis, gluconeogenesis, insulin suppression)
- Free fatty acids — adrenaline stimulates adipose tissue lipolysis, releasing FFAs for fuel during stress
- Metabolic flexibility — chronic adrenaline impairs ability to switch between glucose and fat oxidation
- BDNF — exercise-induced adrenaline surge stimulates BDNF release from brain and muscle